Lung cancer is a common disease and the leading cause of cancer-related mortality, with
non-small cell lung cancer (NSCLC) accounting for the majority of cases. Following …

The use of PET/CT imaging in the work-up and management of patients with lung cancer
has greatly increased in recent decades. The ability to combine functional and anatomical …

Positron emission tomography (PET) is an important modality in the field of molecular
imaging, which is gradually impacting patient care by providing safe, fast, and reliable …

Purpose The aim of this study was to prospectively evaluate the role of various quantitative
and semiquantitative metabolic parameters derived from dynamic and static baseline 18 F …

To evaluate the prognosis of non-small cell lung cancer (NSCLC) patients according to
endobronchial metastatic lesion (EML), especially those not identified on positron emission …

Purpose To investigate the ability of a PET/CT-based radiomics nomogram to predict occult
lymph node metastasis in patients with clinical stage N0 non-small cell lung cancer …

Purpose This study aimed to develop and validate a nomogram for predicting the
malignancy of small (8–20 mm) solid indeterminate solitary pulmonary nodules (SPNs) in a …

Early detection of tumor response to therapy is crucial to the timely identification of the most
efficacious treatments. We recently developed a novel apoptosis imaging tracer, 18F-C …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT), has become a critical advanced imaging technique in oncology. With PET …

Lung cancer is the most common cancer worldwide and the leading cause of cancer-related
deaths in the United States. 1 Late-stage detected cancers have a 5-year survival of 5 …